From Italian genius and creativity comes Phimomed Srls, a company that develops innovative solutions in the medical field, drawing on the great expertise and diversity of a team of researchers.

Phimomed came into being with Phimostop, a project designed to offer men with phimosis a valid alternative to circumcision surgery. Researchers have therefore developed a medical device that allows for the regression of phimosis by exploiting the natural propensity of epidermal tissue to change through gradual and progressive dilation.

Phimostop is a European patent and a CE mark. It has also been the subject of painstaking clinical research at the Tor Vergata University Hospital in Rome and was awarded a gold medal at the International Exhibition of Inventions in Geneva.

Phimostop is constantly being updated and revised; this desire to improve has led to the release of the third version of Phimostop, which is even more ergonomic and customer-oriented.

Entirely Made in Italy, Phimomed has rapidly expanded into the European market and aims to develop worldwide in the near future.

Phimomed has the male audience as its main focus, as demonstrated by the CanEnter project, with the aim of offering a support tool to the many men suffering from total erectile dysfunction.